331A — Medix Balance Sheet
0.000.00%
- ¥4bn
- ¥680m
- ¥4bn
Annual balance sheet for Medix, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | Yuho |
| Standards: | JAS | JAS | JAS |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Cash and Short Term Investments | 2,364 | 2,780 | 3,771 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 2,242 | 2,293 | 2,227 |
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 4,715 | 5,175 | 6,102 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 112 | 132 | 115 |
| Net Intangible Assets | |||
| Long Term Investments | |||
| Long Term Notes Receivable | |||
| Other Long Term Assets | |||
| Total Assets | 5,432 | 5,904 | 6,670 |
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 2,962 | 3,125 | 2,833 |
| Long Term Debt | |||
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Funded Status | |||
| Total Liabilities | 3,702 | 3,747 | 3,401 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Treasury Stock | |||
| Total Equity | 1,730 | 2,157 | 3,269 |
| Total Liabilities & Shareholders' Equity | 5,432 | 5,904 | 6,670 |
| Total Common Shares Outstanding |